“We are very proud - now for the fourth consecutive year - to be selected by EIC for participation at BIO 2025. This is one of the most important conferences in the healthcare and biotech industry, where most leading companies are represented and which will provide us with a great opportunity to keep extending our reach within the rapidly evolving healthcare space,” said Dr. Freltoft. 

In a pitch presentation and the following panel discussion, Dr. Freltoft will present AcouSort’s innovative technology on Wednesday 18, 3-4pm EST. In the session, titled Digital, wireless, smart: Integrated care in the clinic, he will bring insights into how automated sample preparation is an important cornerstone in the healthcare future.

The delegates of the European Pavilion were selected based on their internationalization goals, technological fit with the scope of the trade fair, as well as their capacity to create business through their participation. During BIO 2025, AcouSort will also focus on partnering and 1-on-1 meetings, discussing future OEM solutions within both point-of-care diagnostics and cell therapy.

As BIO 2025 attracts 20,000+ biotechnology and pharma leaders, it offers a fantastic opportunity to identify new opportunities and promising partnerships. BIO 2025 will feature more than 100 interactive sessions across four days, covering business development, a variety of diagnostic areas as well as next generation biotherapeutics.